(Q45013727)

8 December 2017

A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care (English)

1 reference

8 December 2017

1 reference

Paul Kiritzé-Topor

1

1 reference

8 December 2017

Dominique Huas

2

1 reference

8 December 2017

Claude Rosenzweig

3

1 reference

8 December 2017

Sylvie Comte

4

1 reference

8 December 2017

François Paille

5

1 reference

8 December 2017

Philippe Lehert

6

1 reference

8 December 2017

10 August 2004

1 reference

8 December 2017

Alcohol and Alcoholism

1 reference

8 December 2017

39

1 reference

8 December 2017

520-527

1 reference

8 December 2017

6

1 reference

MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients.

8 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

Pragmatic versus explanatory trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The SECCAT survey: I. The costs and consequences of alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

Improvement in quality of life after treatment for alcohol dependence with acamprosate and psychosocial support

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The functioning and well being of persons who seek treatment for drug and alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

Alcohol use disorders, consumption patterns, and health-related quality of life of primary care patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH088

21 January 2018

Identifiers

DOI

10.1093/ALCALC/AGH088

1 reference

8 December 2017

1 reference